Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
39551436 | 0 | Warkentin TE, Geerts W, Sheppard JI, et al. High-dose IVIG and usual heparin anticoagulation for urgent cardiac surgery in a patient with severe autoimmune HIT. J Thromb Haemost. 2024 Nov 15:S1538-7836(24)00687-1. doi: 10.1016/j.jtha.2024.10.035. | |
39122193 | 0 | Galanaud JP, Krebs-Drouot L, Genty-Vermorel C, et al. Very Long-term Risk of Moderate-Severe Post-Thrombotic Syndrome after Deep Vein Thrombosis. J Thromb Haemost. 2024 Aug 7:S1538-7836(24)00438-0. doi: 10.1016/j.jtha.2024.07.020. | |
38917440 | 0 | Geerts WH, Jeong E, Robinson LR, et al. Venous Thromboembolism Prevention in Rehabilitation: a Review and Practice Suggestions. Am J Phys Med Rehabil. 2024 Jun 24. doi: 10.1097/PHM.0000000000002570. | |
38686174 | 0 | Ratnasekera A, Seng SS, Ciarmella M, et al. Thromboprophylaxis in hospitalized trauma patients: a systematic review and meta-analysis of implementation strategies. Trauma Surg Acute Care Open. 2024 Apr 25;9(1):e001420. doi: 10.1136/tsaco-2024-001420. eCollection 2024. | |
36905769 | 0 | Spenard E, Geerts W, Lin Y, et al. Apixaban for extended postoperative thromboprophylaxis in gynecologic oncology patients undergoing laparotomy. Gynecol Oncol. 2023 Mar 9;172:9-14. doi: 10.1016/j.ygyno.2023.02.012. | |
36729882 | 0 | Ratnasekera A, Geerts W, Haut ER, et al. Implementation Science Approaches to Optimizing Venous Thromboembolism Prevention in Patients with Traumatic Injuries: Findings from the 2022 Consensus Conference to Implement Optimal VTE Prophylaxis in Trauma. J Trauma Acute Care Surg. 2022 Dec 6. doi: 10.1097/TA.0000000000003850. | |
34232455 | 0 | Carlin S, Geerts W, Khosravani H. The clot thickens-enhanced integration of stroke and thrombosis training. J Thromb Thrombolysis. 2021 Jul 7. pii: 10.1007/s11239-021-02502-7. doi: 10.1007/s11239-021-02502-7. | |
33872825 | 0 | Carlin S, Bond A, Gross P, et al. Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey. Thromb Res. 2021 Jun;202:176-181. doi: 10.1016/j.thromres.2021.04.004. Epub 2021 Apr 15. | |
33476900 | 0 | Fitzpatrick T, Wong C, Shen C, et al. Quality of anticoagulation using intravenous unfractionated heparin for cerebrovascular indications. Thromb Res. 2021 Mar;199:79-81. doi: 10.1016/j.thromres.2020.12.027. Epub 2021 Jan 7. | |
31129575 | 0 | Kahn SR, Diendere G, Morrison DR, et al. Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2019 May 24;9(5):e024444. doi: 10.1136/bmjopen-2018-024444. | |
30384119 | 0 | Hachem LD, Mansouri A, Scales DC, et al. Anticoagulant prophylaxis against venous thromboembolism following severe traumatic brain injury: A prospective observational study and systematic review of the literature. Clin Neurol Neurosurg. 2018 Dec;175:68-73. doi: 10.1016/j.clineuro.2018.09.032. Epub 2018 Sep 26. | |
29856817 | 0 | Pai M, Adhikari NKJ, Ostermann M, et al. Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial. PLoS One. 2018 Jun 1;13(6):e0198285. doi: 10.1371/journal.pone.0198285. eCollection 2018. | |
29687454 | 0 | Kahn SR, Morrison DR, Diendere G, et al. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. Cochrane Database Syst Rev. 2018 Apr 24;4:CD008201. doi: 10.1002/14651858.CD008201.pub3. | |
29233324 | 0 | Diamantouros A, Marchesano R, Geerts WH, et al. Development and evaluation of a continuing pharmacy education (CPE) program in thrombosis management. Curr Pharm Teach Learn. 2017 Sep;9(5):911-917. doi: 10.1016/j.cptl.2017.05.008. Epub 2017 Jul 14. | |
29222322 | 0 | Geerts W, Selby R. Inferior vena cava filter use and patient safety: legacy or science? Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):686-692. doi: 10.1182/asheducation-2017.1.686. | |
29112542 | 0 | Faraoni D, Comes RF, Geerts W, et al. European guidelines on perioperative venous thromboembolism prophylaxis: Neurosurgery. Eur J Anaesthesiol. 2018 Feb;35(2):90-95. doi: 10.1097/EJA.0000000000000710. | |
28973248 | 0 | Wallis CJD, Juvet T, Lee Y, et al. Association Between Use of Antithrombotic Medication and Hematuria-Related Complications. JAMA. 2017 Oct 3;318(13):1260-1271. doi: 10.1001/jama.2017.13890. | |
28583301 | 0 | Diamantouros A, Kiss A, Papastavros T, et al. The TOronto ThromboProphylaxis Patient Safety Initiative (TOPPS): A cluster randomised trial. Res Social Adm Pharm. 2017 Sep - Oct;13(5):997-1003. doi: 10.1016/j.sapharm.2017.05.015. Epub 2017 May 27. | |
26817956 | 0 | McGowan KE, Makari J, Diamantouros A, et al. Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program. Blood. 2016 Apr 21;127(16):1954-9. doi: 10.1182/blood-2015-07-660001. Epub 2016 Jan 27. | |
26489742 | 0 | Aloia TA, Geerts WH, Clary BM, et al. Venous Thromboembolism Prophylaxis in Liver Surgery. J Gastrointest Surg. 2016 Jan;20(1):221-9. doi: 10.1007/s11605-015-2902-4. | |
26121536 | 0 | Gladstone DJ, Geerts WH, Douketis J, et al. How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society. Ann Intern Med. 2015 Sep 1;163(5):382-5. doi: 10.7326/M15-0143. | |
25900749 | 0 | Selby R, Geerts WH, Kreder HJ, et al. A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures. J Orthop Trauma. 2015 May;29(5):224-30. doi: 10.1097/BOT.0000000000000250. | |
25474533 | 0 | Lim W, Meade M, Lauzier F, et al. Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med. 2015 Feb;43(2):401-10. doi: 10.1097/CCM.0000000000000713. |